The largest database of trusted experimental protocols

4 protocols using h 2db

1

Multicolor Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained for extracellular molecular expression patterns using mAbs against mouse CD3 (APC–Cy5 conjugated), CD4 (Pacific Blue conjugated), CD8 (V450 conjugated), CD45R/B220 (PE conjugated), CD11b (PE–Cy5 conjugated), F4/80 (PE–Cy7 conjugated; V450 conjugated), Ly6G (APC conjugated), CD25 (APC conjugated), FOXP3 (PE conjugated), H-2Db (Alexa Fluor-647 conjugated; BioLegend), and H-2Kb/H-2Db (PE conjugated; BioLegend). All antibodies were purchased from BD. The frequency of positive cells was analyzed using a gate that included lymphocytes, granulocytes, and/or monocytes/macrophages. Limits for the quadrant markers were always set based on negative populations and isotype control antibodies. Cells were acquired with a BD FACSCanto II cytometer and analyzed using FlowJo 7.5.3 software. The frequency (percentage) of the analyzed population in the total acquired events was used in the construction of the graphs.
+ Open protocol
+ Expand
2

Immunophenotyping Mouse Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies for flow cytometry were obtained from BD Biosciences (CD8α, CD4, B220, TCRβ, CD44, NK1.1, Qa-1b, CD11c, H2-Kb, H2-Db, I-Ab and IFNγ ) and BioLegend (CD62L). All peptides were synthesized by Dr. David King (UC Berkeley).
+ Open protocol
+ Expand
3

Single Cell Immunophenotyping of MOC2 Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Only fresh cultured cells or tissue prepared into single cell suspensions were analyzed. The harvest and digestion of MOC2 tumors into single cell suspensions for analysis was performed as previously described [18 ]. Nonspecific surface staining was minimized by staining with CD16/32 (FcR) blocking antibodies for 10 min prior to the addition of primary antibodies when applicable. Anti-mouse NK1.1, CD3, CD16, NKG2D, CD44, CD27, PD-L1, PD-1, Tim-3, CTLA-4, H-2Kb, H-2Db, pan-RAE, H60 and MULT-1 antibodies were from Biolegend. For some experiments, pre-treatment of cells with interferon γ (IFNγ) (20 ng/mL × 24 h) or YAC cells were used as positive controls. Primary antibodies were applied for 30–60 min at concentrations titrated for each antibody. Dead cells were excluded via 7AAD uptake and a “fluorescence-minus-one” technique was used to validate specific staining in all antibody combinations. Intracellular staining was performed with the eBioscience Intracellular Fixation and Permeabilization Buffer Set per manufacturer protocol. Granzyme B and IFNγ antibodies were from Biolegend. All analyses were performed on a BD FACSCanto analyzer running FACSDiva software and interpreted using FlowJo (vX10.0.7r2).
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry of Tumor-Immune Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell concentration was determined using 123 count eBeads (eBioscience). Cells were first incubated with Fc-block prior to antibody staining. The following antibodies were used from Biolegend: CD8 (53-6.7), CD4 (RM4-5), CD25 (PC61), CD44 (IM7), CD62L (MEL-14), PD1 (29F.1A12), TIM-3 (RMT3-23), CD38 (90), TNF-α (MP6-XT22), F4/80 (BM8), CD103 (2E7), CD45 (104), CD11c (N418), MHCII (M6/114.15.2), Ly6G (HK1.4), CD11b (M1/70); from BD Bioscience: Ki67, Ki67 isotype (RTK4530), and IFN-γ (XMG1.2); from Cell Signaling: TCF1 (C63D9) and Anti-rabbit 2nd; from Invitrogen: CD101 (Invitrogen, Moushi101) and FoxP3 (FJK-16s). Tumor antigen-specific T cells were stained with H2-Db/CEA526−533 EAQNTTYL tetramer (NIH Tetramer Core Facility). Intracellular staining was performed using Cytofix/Cytoperm kit (BD). For tumor cells, the following antibodies were used: CEA (B1.1, BD Bioscience), H2-Db (KH95, Biolegend), Calreticulin (polyclonal, ThermoFisher), PD-L1 (10F.9G2, Biolegend), and CD45 (104, Biolegend). Cells were run on LSRFortessa (BD) flow cytometer and data were analyzed in FlowJo X. The analysis for tumor cells was on GFP+CD45– population.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!